Skip to the guide

First read Check a name

Care questions A question kit for prescriber searches

What it costs Visit question kit

After the first conversation

# Who stays in the conversation after the visit?

A prescription does not answer how later questions will be handled. Ask for that part of the plan in writing too.

Make later care part of the opening conversation.

Before you leave the visit

If the plan later changes

The next review

When do we meet again, and what are we reviewing?

The reason to change

What information would lead us to rethink the plan?

Questions between visits

How do I reach a clinician, and who answers when they are away?

A break in access

If I leave, how will my records and treatment plan reach my next clinician, and who will explain my care to them?

The ongoing bill

What renews, what is optional and how can I end a membership?

A supply or coverage change

Who helps if the prescription cannot be filled or my plan stops paying?

## Ask what progress means for your care

Ask which changes matter for the condition being treated and how they will be reviewed. Say what would make the plan hard to continue, whether that is cost, time or the way care is delivered.

The semaglutide (Wegovy) label names blood-sugar checks for people with diabetes, heart-rate review and kidney checks when fluid loss is a concern.

That is an example of product-specific follow-up, not a test list for everyone. Ask which checks fit your own medicine and history.

## Ask about stopping before it becomes urgent

In the STEP 1 extension, the year following semaglutide withdrawal brought a regain of about two-thirds of the weight participants had lost earlier.

That was a trial finding, not an instruction that every person must stay on treatment indefinitely.

Ask how the clinician would plan a change if the treatment no longer fits. Discuss how care will pass to another clinician, along with medicine questions and costs.

### My follow-up plan

Next review; who answers questions; urgent-help instructions; sending records and the care plan to the next clinician:

Why follow-up has its own questions A label and a trial can frame a discussion. The plan still needs to be made with the clinician who knows your situation.

Semaglutide (Wegovy) product label

Journal record: weight after semaglutide stopped

## Keep the unresolved questions open

Return to the visit question kit

Care questions

This guide helps you find your footing in care; it does not treat patients or fill orders.

Medicine names Red flags Common questions Source notes

Read this page as text Guide text index